miR-122-5p-SOX4

Guanghui Ren1, Kaining Jia2, Sitong Yi1

  • 1Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Journal of viral hepatitis
|February 20, 2026
PubMed
概括

与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 可能抑制慢性乙型肝炎 (CHB) 病毒活性. 一个新的miR-122/SOX4通路被确定为这种相互作用的关键调节器,为肝脏疾病提供潜在的治疗点.